A post-hoc analysis of an RCT investigated the expression of chemokine C-C motif ligand 2 (CCL2), a pro-inflammatory chemokine, in 55 CRC patients with liver metastases randomized to 2g EPA daily or placebo for an average of 30 days prior to surgery [32]. Here, CCL2 is linked to colorectal carcinoma.